Featured Story BRIXTON BIOSCIENCES’ COOLIO™ THERAPY GRANTED BREAKTHOUGH DEVICE DESIGNATION BY FDA October 26, 2023-Brixton Biosciences
Sera Prognostics and Newborn Foundation Partner to Reduce Risks Associated with Preterm Birth and Improve Health Equity Through the “Every Mother, Every Baby” Project May 5, 2022-Sera Prognostics
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting March 18, 2022-Sera Prognostics
Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest March 16, 2022-Avive
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System February 16, 2022-Epitel
AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study December 20, 2021-AtaCor Medical
Sera Prognostics Announces Collaboration to Help Underserved Communities Make Informed Decision about Prenatal Health November 4, 2021-Sera Prognostics
PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer October 15, 2021-PanTher Therapeutics
